AR053862A1 - Sales de monolisina de compuestos de triazol - Google Patents
Sales de monolisina de compuestos de triazolInfo
- Publication number
- AR053862A1 AR053862A1 ARP060101759A ARP060101759A AR053862A1 AR 053862 A1 AR053862 A1 AR 053862A1 AR P060101759 A ARP060101759 A AR P060101759A AR P060101759 A ARP060101759 A AR P060101759A AR 053862 A1 AR053862 A1 AR 053862A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- formula
- monolisine
- salts
- groups selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Composiciones farmacéuticas que los contienen, métodos de preparacion y usos para el tratamiento de infecciones fungicas. Reivindicacion 1: Una sal de mono-lisina caracterizado por ser un compuesto de formula (1), o un solvato de la misma en la cual cada uno de R y R1 es un H o alquilo c1-6; y A se selecciona del grupo constituido por el grupo de formulas (2) y una formula (3) en donde en la formula (3) R3 representa un grupo fenilo sustituido con uno o más átomos de halogeno; R4 representa un H o CH3; R5 representa un H o, considerado junto con R4, representa =CH2; y R6 representa un tiazolilo, pirimidinilo o tri-azolilo en donde cada anillo está sustituido opcionalmente con uno o más grupos seleccionados del grupo constituido por un halogeno, =O, CH=CH-(C6H4)-OCH2CF2CHF2, y un fenilo sustituido con uno o más grupos seleccionados del grupo constituido por CN y OCH2CF2CHF2, o un fenilo sustituido con uno o más grupos seleccionados del grupo constituido por un halogeno y metilpirazolilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67693205P | 2005-05-03 | 2005-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR053862A1 true AR053862A1 (es) | 2007-05-23 |
Family
ID=36910951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060101759A AR053862A1 (es) | 2005-05-03 | 2006-05-02 | Sales de monolisina de compuestos de triazol |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20060264406A1 (es) |
| EP (1) | EP1877403B1 (es) |
| JP (1) | JP4015691B1 (es) |
| KR (1) | KR100887044B1 (es) |
| CN (1) | CN101213193B (es) |
| AR (1) | AR053862A1 (es) |
| AT (1) | ATE503753T1 (es) |
| AU (1) | AU2006241694B2 (es) |
| BR (1) | BRPI0610423B8 (es) |
| CA (1) | CA2606185C (es) |
| CY (1) | CY1111569T1 (es) |
| DE (1) | DE602006020998D1 (es) |
| DK (1) | DK1877403T3 (es) |
| EC (1) | ECSP077812A (es) |
| ES (1) | ES2361768T3 (es) |
| HR (1) | HRP20110467T1 (es) |
| IL (1) | IL187059A (es) |
| JO (1) | JO2691B1 (es) |
| MX (1) | MX2007013605A (es) |
| MY (1) | MY138095A (es) |
| NO (1) | NO20075541L (es) |
| NZ (1) | NZ563092A (es) |
| PE (1) | PE20071423A1 (es) |
| PL (1) | PL1877403T3 (es) |
| PT (1) | PT1877403E (es) |
| RS (1) | RS51779B (es) |
| RU (1) | RU2399625C2 (es) |
| SA (1) | SA06270126B1 (es) |
| SI (1) | SI1877403T1 (es) |
| TW (1) | TWI363630B (es) |
| UY (1) | UY29507A1 (es) |
| WO (1) | WO2006118351A1 (es) |
| ZA (1) | ZA200709127B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2632842C (en) | 2005-12-20 | 2013-06-25 | Eisai R & D Management Co., Ltd. | Process for preparation of water-soluble azole prodrugs |
| US9931295B2 (en) | 2006-02-22 | 2018-04-03 | Eisai R&D Management Co., Ltd. | Stabilized pharmaceutical composition |
| CN105287403A (zh) * | 2014-08-02 | 2016-02-03 | 陕西合成药业股份有限公司 | 一种泊沙康唑前体药物的冻干组合物及其制备方法和用途 |
| CN106432338A (zh) * | 2015-08-08 | 2017-02-22 | 陕西合成药业股份有限公司 | 泊沙康唑衍生物、合成和在长效制剂中的用途 |
| WO2019106571A1 (en) | 2017-11-28 | 2019-06-06 | Roivant Sciences Gmbh | Dosing regimens for the treatment of fungal infections |
| CN110938093B (zh) * | 2018-09-21 | 2022-08-19 | 华创合成制药股份有限公司 | 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK283035B6 (sk) * | 1993-12-21 | 2003-02-04 | Schering Corporation | Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok |
| EP0741737B1 (en) * | 1994-01-24 | 1999-11-10 | Janssen Pharmaceutica N.V. | Watersoluble azole antifungals |
| NZ270418A (en) * | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
| US5883097A (en) * | 1998-04-16 | 1999-03-16 | Schering Corporation | Soluble azole antifungal salt |
| US6265584B1 (en) * | 1998-05-22 | 2001-07-24 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| AU1915500A (en) * | 1998-11-20 | 2000-06-13 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6235728B1 (en) * | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
| US6362172B2 (en) * | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
-
2006
- 2006-04-17 JO JO2006103A patent/JO2691B1/en active
- 2006-04-28 UY UY29507A patent/UY29507A1/es active IP Right Grant
- 2006-04-28 MY MYPI20061985A patent/MY138095A/en unknown
- 2006-05-01 BR BRPI0610423A patent/BRPI0610423B8/pt active IP Right Grant
- 2006-05-01 SI SI200630984T patent/SI1877403T1/sl unknown
- 2006-05-01 WO PCT/JP2006/309435 patent/WO2006118351A1/en not_active Ceased
- 2006-05-01 RS RS20110275A patent/RS51779B/sr unknown
- 2006-05-01 AT AT06746245T patent/ATE503753T1/de active
- 2006-05-01 CN CN2006800150290A patent/CN101213193B/zh not_active Expired - Fee Related
- 2006-05-01 DE DE602006020998T patent/DE602006020998D1/de active Active
- 2006-05-01 RU RU2007140788/04A patent/RU2399625C2/ru active
- 2006-05-01 PL PL06746245T patent/PL1877403T3/pl unknown
- 2006-05-01 ES ES06746245T patent/ES2361768T3/es active Active
- 2006-05-01 PT PT06746245T patent/PT1877403E/pt unknown
- 2006-05-01 KR KR1020077001773A patent/KR100887044B1/ko not_active Expired - Fee Related
- 2006-05-01 EP EP06746245A patent/EP1877403B1/en active Active
- 2006-05-01 HR HR20110467T patent/HRP20110467T1/hr unknown
- 2006-05-01 CA CA2606185A patent/CA2606185C/en active Active
- 2006-05-01 JP JP2007509811A patent/JP4015691B1/ja active Active
- 2006-05-01 NZ NZ563092A patent/NZ563092A/en not_active IP Right Cessation
- 2006-05-01 DK DK06746245.7T patent/DK1877403T3/da active
- 2006-05-01 MX MX2007013605A patent/MX2007013605A/es active IP Right Grant
- 2006-05-01 AU AU2006241694A patent/AU2006241694B2/en not_active Ceased
- 2006-05-02 PE PE2006000458A patent/PE20071423A1/es active IP Right Grant
- 2006-05-02 AR ARP060101759A patent/AR053862A1/es not_active Application Discontinuation
- 2006-05-03 TW TW095115682A patent/TWI363630B/zh not_active IP Right Cessation
- 2006-05-03 US US11/416,322 patent/US20060264406A1/en not_active Abandoned
- 2006-05-03 SA SA06270126A patent/SA06270126B1/ar unknown
-
2007
- 2007-10-16 EC EC2007007812A patent/ECSP077812A/es unknown
- 2007-10-23 ZA ZA200709127A patent/ZA200709127B/en unknown
- 2007-10-31 IL IL187059A patent/IL187059A/en active IP Right Grant
- 2007-11-02 NO NO20075541A patent/NO20075541L/no not_active Application Discontinuation
-
2011
- 2011-06-17 CY CY20111100582T patent/CY1111569T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20220567A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20230322A1 (es) | Aminotiazoles sustituidos como inhibidores de dgkzeta para la activacion inmune | |
| PE20070370A1 (es) | Compuestos derivados de carboxamidas como agentes fungicidas | |
| AR064876A1 (es) | Composiciones de amino alcohol y biocidas para sistemas de base acuosa | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| PE20181298A1 (es) | Inhibidores de bromodominio bivalentes y usos de los mismos | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR072224A1 (es) | Derivados de pirimidona sustituidos | |
| AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
| AR081058A1 (es) | Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer. | |
| AR076860A1 (es) | Derivados de 7-aril- 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos. | |
| AR065863A1 (es) | Derivados de imidazolidinona | |
| CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| AR050540A1 (es) | Derivados de adamantilamida triciclica como inhibidores de deshidrogenasa 11- beta hidroxiesteroide | |
| AR074109A1 (es) | Pirrolidinas heterociclicas agonistas de receptores de la melanocortina, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de la obesidad, diabetes y disfuncion erectil. | |
| AR058077A1 (es) | Derivados de acidos fenoxiaceticos | |
| AR058073A1 (es) | Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos | |
| AR058043A1 (es) | Derivados plaguicidas de fenilamidina benciloxi y fenetil sustituidos | |
| AR065583A1 (es) | Compuestos macrociclicos y composicion farmaceutica | |
| MX2021008252A (es) | Compuesto de pirimidina o sal del mismo. | |
| AR068373A1 (es) | Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen | |
| AR069781A1 (es) | Compuestos de n-(2,3-dihidro-inden-2-il) propanosulfonamida, composicion farmaceutica que los comprenden y su uso para el tratamiento de la ezquizofrenia. | |
| AR053862A1 (es) | Sales de monolisina de compuestos de triazol | |
| AR058928A1 (es) | Piperazinas y piperidinas como potenciadoras de mglur5. usos y composiciones farmaceuticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |